AnaCardio (private company)
See something wrong or missing? Let us know
Offices:Stockholm
Industry:Health servicesManufacturingPharma
Business model:B2B
AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.
Investors:
we tracked 9 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 32.8M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to AnaCardio
Name | Criteria | |
---|---|---|
![]() |
Beckley Psytech
80%
|
|
![]() |
Baseimmune
80%
|
|
![]() |
Kither Biotech
80%
|
|
![]() |
Relation Therapeutics
80%
|
|
![]() |
Neumirna Therapeutics
80%
|
|
![]() |
Qubit Pharmaceuticals
77%
|
|
![]() |
SolasCure
77%
|
|
![]() |
ViaNautis
77%
|
|
![]() |
Octarine Bio
75%
|
|
![]() |
Brenus Pharma
73%
|
|